Literature DB >> 17201625

Reboxetine use in the treatment of attention-deficit/hyperactivity disorder.

Halime T Cak, Füsun Cuhadaroğlu Cetin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17201625     DOI： 10.1089/cap.2006.16.803

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  1 in total

1.  Effectiveness of reboxetine in treatment of outpatient children and adolescents with attention deficit-hyperactivity disorder with comorbid anxiety disorders.

Authors:  Forough Riahi; Ashraf Tashakori; Sakineh Izadi-Mazidi; Mohammad Salehi-Veysi
Journal:  Iran J Psychiatry       Date:  2013-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.